Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2010 (2010), Article ID 854527, 5 pages
http://dx.doi.org/10.4061/2010/854527
Research Article

Intereleukin-10 Promoter Polymorphism in Mild Cognitive Impairment and in Its Clinical Evolution

1Department of Internal Medicine, Università degli Studi di Milano, Geriatric Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Via Pace 9, 20122 Milano, Italy
2Department of Internal Medicine and Prevention, Università degli Studi di Milano-Bicocca, Geriatric Clinic, San Gerardo Hospital, Via Pergolesi 33, 20052 Monza, Italy

Received 1 April 2010; Accepted 17 June 2010

Academic Editor: Diana Paleacu

Copyright © 2010 Beatrice Arosio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. L. Price and J. C. Morris, “Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease,” Annals of Neurology, vol. 45, no. 3, pp. 358–368, 1999. View at Google Scholar · View at Scopus
  2. R. C. Petersen, R. Doody, and R. Doody, “Current concepts in mild cognitive impairment,” Archives of Neurology, vol. 58, no. 12, pp. 1985–1992, 2001. View at Google Scholar · View at Scopus
  3. H. W. Querfurth and F. M. LaFerla, “Alzheimer's disease,” The New England Journal of Medicine, vol. 362, no. 4, pp. 329–344, 2010. View at Google Scholar
  4. T. Wyss-Coray, “Inflammation in Alzheimer disease: driving force, bystander or beneficial response?” Nature Medicine, vol. 12, no. 9, pp. 1005–1015, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. E. Tarkowski, K. Blennow, A. Wallin, and A. Tarkowski, “Intracerebral production of tumor necrosis factor-α, a local neuroprotective agent, in Alzheimer disease and vascular dementia,” Journal of Clinical Immunology, vol. 19, no. 4, pp. 223–230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Tarkowski, A.-M. Liljeroth, Å. Nilsson, L. Minthon, and K. Blennow, “Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease,” Dementia and Geriatric Cognitive Disorders, vol. 12, no. 5, pp. 314–317, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Bermejo, S. Martín-Aragón, and S. Martín-Aragón, “Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease,” Immunology Letters, vol. 117, no. 2, pp. 198–202, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. K. Bonotis, E. Krikki, V. Holeva, C. Aggouridaki, V. Costa, and S. Baloyannis, “Systemic immune aberrations in Alzheimer's disease patients,” Journal of Neuroimmunology, vol. 193, no. 1-2, pp. 183–187, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. S. Ray, M. Britschgi, and M. Britschgi, “Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins,” Nature Medicine, vol. 13, no. 11, pp. 1359–1362, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. F. Licastro, E. Porcellini, C. Caruso, D. Lio, and E. H. Corder, “Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation,” Neurobiology of Aging, vol. 28, no. 11, pp. 1637–1643, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. D. Lio, F. Licastro, and F. Licastro, “Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease,” Genes and Immunity, vol. 4, no. 3, pp. 234–238, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. J. M. Kim, C. I. Brannan, N. G. Copeland, N. A. Jenkins, T. A. Khan, and K. W. Moore, “Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes,” Journal of Immunology, vol. 148, no. 11, pp. 3618–3623, 1992. View at Google Scholar · View at Scopus
  13. B. Arosio, D. Trabattoni, and D. Trabattoni, “Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease,” Neurobiology of Aging, vol. 25, no. 8, pp. 1009–1015, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. R. C. Petersen, “Mild cognitive impairment as a diagnostic entity,” Journal of Internal Medicine, vol. 256, no. 3, pp. 183–194, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. Zanetti, C. Ballabio, C. Abbate, C. Cutaia, C. Vergani, and L. Bergamaschini, “Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study,” Journal of the American Geriatrics Society, vol. 54, no. 4, pp. 580–586, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. O. Hansson, H. Zetterberg, P. Buchhave, E. Londos, K. Blennow, and L. Minthon, “Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study,” Lancet Neurology, vol. 5, no. 3, pp. 228–234, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. G. McKhann, D. Drachman, and M. Folstein, “Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease,” Neurology, vol. 34, no. 7, pp. 939–944, 1984. View at Google Scholar
  18. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, p. 1215, 1988. View at Google Scholar · View at Scopus
  19. J. Eskdale, P. Wordsworth, S. Bowman, M. Field, and G. Gallagher, “Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus,” Tissue Antigens, vol. 49, no. 6, pp. 635–639, 1997. View at Google Scholar · View at Scopus
  20. J. Eskdale, G. Gallagher, C. L. Verweij, V. Keijsers, R. G. J. Westendorp, and T. W. J. Huizinga, “Interleukin 10 secretion in relation to human IL-10 locus haplotypes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9465–9470, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. Berlau, M. M. Corrada, E. Head, and C. H. Kawas, “ApoE ε2 is associated with intact cognition but increased Alzheimer pathology in the oldest old,” Neurology, vol. 72, no. 9, pp. 829–834, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. G. Bu, “Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy,” Nature Reviews Neuroscience, vol. 10, no. 5, pp. 333–344, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. P. P. Singh, M. Singh, and S. S. Mastana, “APOE distribution in world populations with new data from India and the UK,” Annals of Human Biology, vol. 33, no. 3, pp. 279–308, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. J. Kim, J. M. Basak, and D. M. Holtzman, “The role of apolipoprotein E in Alzheimer's disease,” Neuron, vol. 63, no. 3, pp. 287–303, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. A. M. Szczepanik, S. Funes, W. Petko, and G. E. Ringheim, “IL-4, IL-10 and IL-13 modulate Aβ(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line,” Journal of Neuroimmunology, vol. 113, no. 1, pp. 49–62, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. C. C. Chao, T. W. Molitor, and S. Hu, “Neuroprotective role of IL-4 against activated microglia,” Journal of Immunology, vol. 151, no. 3, pp. 1473–1481, 1993. View at Google Scholar · View at Scopus
  27. D. Lio, L. Scola, and L. Scola, “Gender-specific association between—1082 IL-10 promoter polymorphism and longevity,” Genes and Immunity, vol. 3, no. 1, pp. 30–33, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. O. Combarros, P. Sánchez-Juan, and P. Sánchez-Juan, “Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk,” Journal of Neural Transmission, vol. 115, no. 6, pp. 863–867, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus